LILIAN MELVIS EVERTS: Open Payments
NPI 1790443786 · DUNCANVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 56 payments from 9 companies in 2025. Trend: 2023 $149 · 2024 $59 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $442 |
| Almatica Pharma LLC | 6 | $133 |
| Supernus Pharmaceuticals, Inc. | 17 | $132 |
| Alkermes, Inc. | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, LOREEV XR, Qelbree, ARISTADA, SPRAVATO, FANAPT, CAPLYTA, Auvelity.
Industry payments across TX — which companies pay providers there.
